Back to Search
Start Over
Role of CC chemokines (macrophage inflammatory protein-1 beta, monocyte chemoattractant protein-1, RANTES) in acute lung injury in rats.
- Source :
-
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2000 Mar 01; Vol. 164 (5), pp. 2650-9. - Publication Year :
- 2000
-
Abstract
- The role of the CC chemokines, macrophage inflammatory protein-1 beta (MIP-1 beta), monocyte chemotactic peptide-1 (MCP-1), and RANTES, in acute lung inflammatory injury induced by intrapulmonary deposition of IgG immune complexes injury in rats was determined. Rat MIP-1 beta, MCP-1, and RANTES were cloned, the proteins were expressed, and neutralizing Abs were developed. mRNA and protein expression for MIP-1 beta and MCP-1 were up-regulated during the inflammatory response, while mRNA and protein expression for RANTES were constitutive and unchanged during the inflammatory response. Treatment of rats with anti-MIP-1 beta Ab significantly decreased vascular permeability by 37% (p = 0.012), reduced neutrophil recruitment into lung by 65% (p = 0.047), and suppressed levels of TNF-alpha in bronchoalveolar lavage fluids by 61% (p = 0.008). Treatment of rats with anti-rat MCP-1 or anti-rat RANTES had no effect on the development of lung injury. In animals pretreated intratracheally with blocking Abs to MCP-1, RANTES, or MIP-1 beta, significant reductions in the bronchoalveolar lavage content of these chemokines occurred, suggesting that these Abs had reached their targets. Conversely, exogenously MIP-1 beta, but not RANTES or MCP-1, caused enhancement of the lung vascular leak. These data indicate that MIP-1 beta, but not MCP-1 or RANTES, plays an important role in intrapulmonary recruitment of neutrophils and development of lung injury in the model employed. The findings suggest that in chemokine-dependent inflammatory responses in lung CC chemokines do not necessarily demonstrate redundant function.
- Subjects :
- Acute Disease
Animals
Antibodies, Blocking administration & dosage
Antigen-Antibody Complex toxicity
Bronchoalveolar Lavage Fluid immunology
Chemokine CCL2 administration & dosage
Chemokine CCL2 antagonists & inhibitors
Chemokine CCL2 genetics
Chemokine CCL4
Chemokine CCL5 administration & dosage
Chemokine CCL5 antagonists & inhibitors
Chemokine CCL5 genetics
Chemokines, CC administration & dosage
Chemokines, CC antagonists & inhibitors
Chemokines, CC genetics
Chemotaxis, Leukocyte immunology
Cloning, Molecular
Immune Sera administration & dosage
Immunoglobulin G toxicity
Intubation, Intratracheal
Lung metabolism
Macrophage Inflammatory Proteins administration & dosage
Macrophage Inflammatory Proteins antagonists & inhibitors
Macrophage Inflammatory Proteins genetics
Male
Pulmonary Alveoli immunology
Pulmonary Alveoli pathology
RNA, Messenger biosynthesis
Rats
Rats, Long-Evans
Recombinant Proteins biosynthesis
Recombinant Proteins immunology
Chemokine CCL2 physiology
Chemokine CCL5 physiology
Chemokines, CC physiology
Lung immunology
Lung pathology
Macrophage Inflammatory Proteins physiology
Subjects
Details
- Language :
- English
- ISSN :
- 0022-1767
- Volume :
- 164
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Journal of immunology (Baltimore, Md. : 1950)
- Publication Type :
- Academic Journal
- Accession number :
- 10679105
- Full Text :
- https://doi.org/10.4049/jimmunol.164.5.2650